Advertisement
Screener

Edwards Lifesciences Corporation (EW) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax

2.9 / 5 stars · 70/120 Roast Me

Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax

Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $4.40 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-28.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2011-02-28

  • Edwards Lifesciences Corporation other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2010 was $4.40M, a 91.30% increase from fiscal 2009.
  • Edwards Lifesciences Corporation other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2009 was $2.30M.
  • Edwards Lifesciences Corporation other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2008 was -$3.10M.
Period endOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month
2010-12-31$4.40M
10-K · filed 2011-02-28
2009-12-31$2.30M
10-K · filed 2011-02-28
2008-12-31-$3.10M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00